Efficacy and safety results from neopembrov study, a randomized phase II trial of neoadjuvant chemotherapy (CT) with or without pembrolizumab (P) followed by interval debulking surgery and standard systemic therapy +/- P for advanced high-grade serous car

Affiliation auteurs!!!! Error affiliation !!!!
TitreEfficacy and safety results from neopembrov study, a randomized phase II trial of neoadjuvant chemotherapy (CT) with or without pembrolizumab (P) followed by interval debulking surgery and standard systemic therapy +/- P for advanced high-grade serous car
Type de publicationJournal Article
Year of Publication2021
AuteursRay-Coquard ILaure, Savoye AMarie, Mouret-Reynier M-A, Chabaud S, Derbel O, Kalbacher E, Leheurteur M, Martinez A, Cornila C, Martinez M, Bengrine L, Priou F, Cloarec N, Venat-Bouvet L, Selle F, Berton D, Collard O, Joly F, Tredan O
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume39
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2021.39.15_suppl.5500